JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1894 SL-327
1 Citation

Target: MEK

Summary: Selective MEK1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥16.75 mg/mL
A8325 Tivantinib (ARQ 197)
2 Citation

Target: MET

Summary: C-Met inhibitor,non-ATP-competitive

≥18.47 mg/mL
A8371 AZ 628

Summary: Raf kinases,potent and ATP-competitive

≥22.6 mg/mL
A8515 Rivastigmine Tartrate

Summary: AChR inhibitor

≥20.02 mg/mL
A8551 INK 128 (MLN0128)
4 Citation

Target: mTOR

Summary: MTOR(TORC-1/-2) inhibitor,potent and selective

insoluble in H2O; ≥15.45 mg/mL
A8616 A-674563

Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK

Summary: Akt1/PKA/CDK2 inhibitor,potent and selective

insoluble in EtOH; ≥23.8 mg/mL
A8627 Bafilomycin A1
31 Citation

Summary: V-ATPases inhibitor

Soluble in DMSO
A8650 Saxagliptin

Target: DPP-4

Summary: Selective DPP4 inhibitor
A8658 AY 9944 dihydrochloride

Summary: Hedgehog Inhibitor

Soluble in H2O
B1585 SC-514

Summary: ATP-competitive IKK-2 inhibitor, orally active

insoluble in EtOH; insoluble in H2O; ≥50.4 mg/mL